From: Changes in practice patterns affecting in-hospital and post-discharge survival among ACS patients
Variables: | Hazard Ratios | 95% CI | p-value | Δχ2-value |
---|---|---|---|---|
Age | 1.01 | 0.99–1.02 | >0.28 | 1.16 |
Gender (male)* | 0.78 | 0.55–1.10 | >0.16 | 2.01 |
Race (white)* | 1.16 | 0.73–1.87 | >0.53 | 0.40 |
Charlson Index*** | 2.03 | 1.43–2.88 | <0.01 | 15.69 |
Ejection Fraction (<35%)* | Â | Â | Â | 8.71** |
   35%–44% | 0.96 | 0.46–2.03 | >0.92 | 0.01 |
   ≥45% | 0.38 | 0.18–0.82 | <0.01 | 6.15 |
   missing | 1.00 | 0.57–1.77 | >0.99 | <0.01 |
Invasive Procedures (none)* | Â | Â | Â | 23.01** |
   CATH | 0.31 | 0.17–0.58 | <0.01 | 13.56 |
   PCI | 0.42 | 0.23–0.79 | <0.01 | 7.21 |
   CABG | 0.19 | 0.08–0.47 | <0.01 | 13.12 |
ACEIs & ARBs – in hospital | 0.44 | 0.31–0.64 | <0.01 | 18.66 |
Beta Blockers – in hospital | 0.73 | 0.48–1.10 | >0.13 | 2.31 |
Aspirin – in hospital | 0.49 | 0.33–0.71 | <0.01 | 13.87 |
Thrombolytics – in hospital | 0.57 | 0.39–0.83 | <0.01 | 8.51 |
Time Cohorts (MICH1)* | Â | Â | Â | 16.95** |
   MICH2 | 1.46 | 0.99–2.15 | >0.05 | 3.57 |
   HARP | 0.16 | 0.05–0.46 | <0.01 | 11.48 |